BASEL, Switzerland, May 20, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announced today the approval by the local Swiss ...

Mescaline, a natural hallucinogen known since ancient times, was not only a favorite of artists and bohemians but also a mainstay of brain research throughout the first half of the 20th century, until ...

Over the past two decades, researchers have published study after study evaluating the therapeutic potential of psychedelics like psilocybin and LSD. The research is so promising that despite being ...

Alcohol use disorder (AUD) has increased during the Covid-19 pandemic Conventional therapies for AUD have limited effectiveness in ensuring long-term remission and harm reduction Journey Colab will ...

TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company developing the next generation of pharmaceuticals to treat ...

TRY to think of an area where plants haven’t benefited us and you will probably come up short. But as well as providing us with food, medicine and textiles, they are a source of psychoactive drugs.

Mescaline: A Global History of the First Psychedelic. By Mike Jay.Yale University Press; 304 pages; $26 and £18.99. MESCALINE IS THE drug that launched the modern fascination with hallucinogens. It is ...

Mention of its consumption might conjure Hunter S. Thompson plunged “into a subhuman funk” or Aldous Huxley recounting “the most extraordinary and significant experience available to human beings this ...

When Aldous Huxley published his essay "The Doors of Perception" in 1954, he did much to publicize a very strange drug. "Mescaline," he writes, "admits one to an other-world of light, color, and ...

WE wish to describe the preliminary pharmacology of a mescaline analogue, 2-(3,4,5-trimethoxyphenyl)-cyclopropylamine (TMT, II). This compound was selected for synthesis as a potential long-acting ...